Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Becker

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Thrombolysis|March 23, 2000
Early and pre-discharge aspirin administration among patients with acute myocardial infarction: current clinical practice and trends in the United StatesR C Becker, M Burns, J M Gore, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2000
Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralizationF A Spencer, S P Ball, Q Zhang, et al.
The American Journal of Surgical Pathology|January 15, 1999
Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 casesL D Thompson, R C Becker, R M Przygodzki, et al.
Cleveland Clinic Journal of Medicine|September 1, 1987
Acquired factor X deficiency in systemic amyloidosisF V Lucas, A J Fishleder, R C Becker, et al.
American Heart Journal|July 1, 1993
Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administrationR C Becker, R Caputo, S Ball, et al.
The American Journal of Cardiology|October 15, 1996
Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarctionM I Furman, R C Becker, J Yarzebski, et al.
Journal of the American College of Cardiology|October 16, 1999
Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potentialR C Becker, F A Spencer, Y Li, et al.
The American Journal of Cardiology|July 13, 2001
Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])F A Spencer, R J Goldberg, P D Frederick, et al.
Journal of Thrombosis and Haemostasis : JTH|April 17, 2012
A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agentJ P Vavalle, C P Rusconi, S Zelenkofske, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
The cleaved peptide of the thrombin receptor is a strong platelet agonistM I Furman, L Liu, S E Benoit, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Thrombolysis|March 23, 2000
Early and pre-discharge aspirin administration among patients with acute myocardial infarction: current clinical practice and trends in the United StatesR C Becker, M Burns, J M Gore, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2000
Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralizationF A Spencer, S P Ball, Q Zhang, et al.
The American Journal of Surgical Pathology|January 15, 1999
Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 casesL D Thompson, R C Becker, R M Przygodzki, et al.
Cleveland Clinic Journal of Medicine|September 1, 1987
Acquired factor X deficiency in systemic amyloidosisF V Lucas, A J Fishleder, R C Becker, et al.
American Heart Journal|July 1, 1993
Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administrationR C Becker, R Caputo, S Ball, et al.
The American Journal of Cardiology|October 15, 1996
Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarctionM I Furman, R C Becker, J Yarzebski, et al.
Journal of the American College of Cardiology|October 16, 1999
Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potentialR C Becker, F A Spencer, Y Li, et al.
The American Journal of Cardiology|July 13, 2001
Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])F A Spencer, R J Goldberg, P D Frederick, et al.
Journal of Thrombosis and Haemostasis : JTH|April 17, 2012
A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agentJ P Vavalle, C P Rusconi, S Zelenkofske, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
The cleaved peptide of the thrombin receptor is a strong platelet agonistM I Furman, L Liu, S E Benoit, et al.
Pageof 15